Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills by Verster, Joris C. & Roth, Thomas
ORIGINAL INVESTIGATION
Predicting psychopharmacological drug effects on actual
driving performance (SDLP) from psychometric tests
measuring driving-related skills
Joris C. Verster & Thomas Roth
Received: 25 May 2011 /Accepted: 31 August 2011 /Published online: 16 September 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Rationale There are various methods to examine driving
ability. Comparisons between these methods and their rela-
tionship with actual on-road driving is often not determined.
Objective The objective of this study was to determine
whether laboratory tests measuring driving-related skills
could adequately predict on-the-road driving performance
during normal traffic.
Methods Ninety-sixhealthyvolunteersperformeda standard-
izedon-the-road driving test. Subjects were instructedtodrive
with a constant speed and steady lateral position within the
right traffic lane. Standard deviation of lateral position
(SDLP), i.e., the weaving of the car, was determined. The
subjects also performed a psychometric test battery including
the DSST, Sternberg memory scanning test, a tracking test,
and a divided attention test. Difference scores from placebo
for parameters of the psychometric tests and SDLP were
computed and correlated with each other. A stepwise linear
regression analysis determined the predictive validity of the
laboratory test battery to SDLP.
Results Stepwise regression analyses revealed that the
combination of five parameters, hard tracking, tracking
and reaction time of the divided attention test, and reaction
time and percentage of errors of the Sternberg memory
scanning test, together had a predictive validity of 33.4%.
Conclusion The psychometric tests in this test battery
showed insufficient predictive validity to replace the on-




The use of central nervous system (CNS) drugs such as
anxiolytics and hypnotics may significantly increase the
risk of having a traffic accident and related injury (Orriols
et al. 2009). The main reason for the increased risk of traffic
accidents is that the use of CNS drugs also can have
adverse effects such as sedation and reduced alertness,
which impair driving ability. Many tests are used to
determine whether drugs may impair performance and to
judge whether patients using these drugs are fit for driving.
To determine whether a test is suitable to examine fitness
for driving, it is important to take note of different models
that describe driving behavior, in particular information
processing and motivational models. Motivational models
focus on the risks drivers are willing to take during driving
(Wilde 1982; Näätänen and Summala 1976; Fuller 1984)
and state that driving behavior is determined by a conscious
cost–benefit analysis between the motives and goals of the
trip and safety risks (Ranney 1994). Drivers adapt their
driving behavior to their personal or environmental needs.
For example, drivers generally adjust their speed under bad
weather conditions but take high risks by speeding in case
of an emergency. In contrast to motivational models,
information processing models analyze driving skills and
abilities at a functional level.
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DOI 10.1007/s00213-011-2484-0Like many behaviors, driving a car is a mix of automatic
and controlled behaviors [Schneider and Shiffrin 1977;
Shiffrin and Schneider 1977). Rasmussen (1987)e x p l a i n s
driving behavior distinguishing three levels of cognitive
control: skill-based, rule-based, and knowledge-based be-
havior (see Fig. 1). Skill-based behavior comprises automatic
and effortless routine driving (e.g., changing gear). In
contrast, rule-based and knowledge-based behaviors are
controlled actions to deal with changing driving circum-
stances. Rule-based behavior follows prescribed rules (e.g.,
passing a slower vehicle). With increased driving experience,
and if the rules show to be effective, rule-based behavior
becomes automatic (skill-based) behavior. If rule-based
behavior is not effective, conscious problem solving (knowl-
edge-based behavior) is necessary to master the new
situation. When the driver becomes familiar with the new
driving situation, behavior starts following rules (rule-based
behavior) or may become more or less automatic (skill-based
level). A similar model by Michon (1985) explained driving
at the strategic (navigation), maneuvering (tactical), and
operational level. Performance at the strategic level is
predominantly memory-driven, controlled processing, and
concerns trip-planning and achievement of goals. Perfor-
mance at the maneuvering level is environmental/data-
driven, controlled processing, and includes normal driving
procedures such as passing other cars or reacting to other
traffic. At the operational level, behavior is automatic and
concerns immediate vehicle control, such as changing gear.
Decisions made at the strategic level take minutes, those
made the maneuvering level are made within seconds, and at
the operational level, decisions are made within 1 s. The
relationship between the models of Rasmussen and Michon
is shown in Fig. 1.
Thus, depending on the relationship between uncertainly
and experience of the driver, driving behaviors can switch
between the three levels of driving behavior and comprise
automatic (fast and effortless) or controlled processing
(slow and effortful). Various methodologies are applied to
determine whether or not a patient is fit for driving when
using a CNS drug, ranging from subjective assessments by
driving instructors and psychometric testing to driving
simulator tests or actual driving tests on public highways.
Cognitive and psychomotor tests are often used to assess
driving-related skills and abilities. Generally, no complex
equipment is required, and the tests are easy to conduct,
relatively cheap, and testing can be done under controlled
standardized conditions. Tests are often of short duration,
and a variety of skills and abilities can be examined. This
makes their use cost-effective and time-efficient. Of vital
importance is that the tests measure a valid psychological
construct (Parrott 1991a, b, c), are sensitive to the effects of
CNS drugs (Hindmarch 1980), and have a clear relationship
with driving. Unfortunately, this often is not the case. For
example, finger tapping and the Critical Flicker Fusion Test
(CFFT) are often included in test batteries, although their
relationship to driving or any other real-life task is unclear.
The presumed rationale for including these tests is that they
are used in other research and showed to be sensitive to
drug-induced impairment. Guidelines and recommenda-
tions on the methodology and tests to determine driving
ability have been published on behalf of the International
Council on Alcohol, Drugs and Traffic Safety (ICADTS)
(Vermeeren et al. 1993; Tailloires Report 2007; Walsh et al.
2008). There is consensus that tests should be (1)
standardized, (2) valid and reliable, (3) be able to
differentiate between dose-dependent drug effects, and (4)
provide information on skills and abilities that are important
during driving such as attention, alertness, vigilance, and
psychomotor performance. These tests should cover perfor-
mance on all levels of driving behavior in order to fully
Fig. 1 A model of driving behavior according to Rasmussen and Michon. Experienced drivers operate at the gray-scaled diagonal of Fig. 2,
whereas novice drivers operate in the upper right corner of the figure
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comes to driving or to determine whether a patient is fit for
driving.
Researchers have combined various psychometric tests
and claimed that their test battery predicts actual driving
(Fitten et al. 1995; Marottoli et al. 1998; McKnight and
McKnight 1999; De Raedt and Pontjaert-Kristoffersen
2001). Their conclusion is often based on the fact that they
find a significant relationship between performance on
cognitive and psychomotor tests and driving performance,
showing a predictive validity up to 85%. In these studies,
driving performance was either judged subjectively by a
driving instructor or researcher, or driving performance was
measured using a driving simulator. Other researchers,
however, reported that their tests had no significant
predictive validity (Galski et al. 1990; Korteling and
Kaptein 1996; Duchek et al. 1998; Bliokas et al. 2011;
Devos et al. 2011). The tests that were included in these
studies vary greatly. An explanation for differences in the
relationship between impairment on cognitive or psycho-
motor tests versus actual driving impairment is that these
tests all have a different sensitivity for drug-induced
impairment. This was shown by Moskowitz and Fiorentino
(2000) who summarized data on several tests and deter-
mined at which blood alcohol concentration (BAC)
significant impairment was demonstrated by the majority
of reviewed studies. Moskowitz and Fiorentino (2000)
reported that BAC levels ranged from 0.1% to 1.0%,
depending on the test that was chosen (see Fig. 2).
A study by Myers et al. (2000) illustrates that the choice
of tests is of great importance. In their study, a laboratory
test battery comprising visual screening, a reaction time
task, a split-attention task, a visual organization test, and a
verbal and symbolic sign recognition test did not adequately
predict on-road driving performance of patients referred for
evaluation of their driving skills. However, applying the
Useful Field Of View test (UFOV, a three-part test, measuring
speed of visual processing, ability to divide attention, and
selective attention) a predictive validity of 86% was found.
Two major limitations of the methodology to assess actual
driving performance prevent a fair judgment of the test
batteries used in the studies discussed above. First, subjective
assessments of driving performance often lack standardiza-
tion, and reliability and validity are not determined (Fox et al.
1998). Also, simple ratings of driving performance (e.g.,
visual analog scales or passing/failing judgments) do not
sufficiently differentiate between performance levels. A
recent comparison also showed that drivers themselves also
poorly predict their own driving performance (Verster and
Roth 2011a). Second, it can also be questioned if assess-
ments in a driving simulator can adequately predict actual
driving. Although today, very advanced driving simulators
are available, it remains a test in an artificial environment,
the test may be experienced as a game, and in contrast to on-
road driving the test poses no real safety risks. Therefore, it
is likely that motivation to perform a driving simulator test is
different from on-road driving (Verster and Roth 2011a).
As stated by O'Hanlon (1988), a realistic driving test is
needed to assess the safe use of drugs by drivers. In their
effort to mimic actual driving circumstances, researchers
also used closed roads to test driving performance (e.g.,
Betts and Birtle 1982). Closed road tests often comprise
testing specific driving behaviors, such as maneuvering the
vehicle along a circuit of cones, gap judgment, parking, or
measuring break reaction time (e.g., Tashiro et al. 2005).
Although it may be interesting to examine what happens in
these special circumstances, the obtained data provides little
information on how drivers will behave in normal traffic.
Another major disadvantage of this approach is that other
traffic is not present during the test. Since interacting with
other drivers is an essential element of participating in traffic,
this greatly limits the ecological validity of these tests.
Taken together, the subjective nature of the on-road
assessments, the use of driving simulator assessments, and
the questionable relevance to driving of some of the included
tests, probably accounts for the inconclusive results of studies
that aimed at developing a suitable test battery to replace
actual driving tests.
Currently, the on-the-road driving test in normal traffic is
regarded as the gold standard to examine driving ability
(O'Hanlon et al. 1982; VersterandRoth2011b). This 100-km
driving test is performed on a public highway in normal
traffic. Participants are instructed to drive with a steady
lateral position within the right traffic lane and a constant
speed (95 km/h). The primary outcome measure is the
Standard Deviation of Lateral Position (SDLP), i.e., the
weaving of the car. A disadvantage of the test is that it is time
consuming and relatively expensive and requires an instru-
mented vehicle and trained personnel. Therefore, it would be
more efficient to have an easy to use psychometric test battery
that could predict actual driving. Cognitive and psychomotor
tests can provide valuable information about specific impair-
Fig. 2 Blood alcohol concentration (BAC) at which more than half of
tests showed significant impairment (Moskowitz and Fiorentino 2000)
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can predict actual driving performance, they could serve as a
time-andcost-effectivesafealternativeforon-the-roaddriving
tests.
Ramaekers (2003) correlated changes in driving perfor-
mance (SDLP) and performance in seven psychometric tests
(tracking, divided attention, reaction time, vigilance, Critical
Flicker Fusion test, tapping, and memory). Analyzing data
from two studies (N=32 in total), he found that correlations
were at best relatively modest (r=0.2 to 0.4). Correlation was
highest between SDLP and the tracking test.
In the current study, data from a larger sample of healthy
volunteers was analyzed, who participated in three studies
examining the effects of various CNS drugs on both on-the-
road driving and a number of psychometric test. The
objective was to determine to what extend performance on
the psychometric tests predicts on-the-road driving perfor-
mance (SDLP), alone or in combination.
Methods
Data from three studies was used to compose the current
data set (Verster et al. 2002a,b, 2003a,b, 2006). The Medical
Ethics Committee of the University Medical Center Utrecht
approved the study protocols, and subjects were treated
according to ICH guidelines for Good Clinical Practice and
the Declaration of Helsinki and its amendments.
Participants
A total of 96 healthy male and female volunteers completed
the three studies. Mean (SD) age was 23.9 (2.2)years old.
Written informed consent was obtained before their
inclusion. Subjects were medically screened, used no
concomitant medication other than acetaminophen and oral
contraceptives, and they had no history of alcohol or drug
abuse. Before the start and at the end of the studies, blood
chemistry and hematology and urinalysis were determined,
and a 12-lead ECG was recorded. All assessments were
within normal limits. To confirm compliance, at all visits,
subjects were tested on the presence of alcohol and drugs of
abuse (amphetamines, barbiturates, cannabinoids, benzo-
diazepines, cocaine, and opioids). In addition, female
subjects underwent β-HCG pregnancy tests. None of the
subjects were positive on any of these tests. Subjects
possessed a valid driver's license and drove more than
5,000 km/year during each of the past 3 years. A thorough
discussion on the inclusion and exclusion criteria of
participants and description of the study designs can be
found elsewhere (Verster et al. 2002a, b, 2003a, b, 2006). In
each study, subjects performed an on-road driving test and a
psychometric test battery. The design of the studies was set
up in a balanced manner: half of the subjects first
performed the driving test, whereas the other half first
performed the psychometric test battery.
Treatments
A variety of treatments were tested in the three studies,
including alcohol, hypnotics, anxiolytics, analgesics, and
antihistamine drugs. Study 1 (part 1) examined the residual
effects of zaleplon (10 and 20 mg) and zolpidem (10 and
20 mg), 4–6 h after middle of the night administration
(Verster et al. 2002a). The results were compared to a single
dose of alcohol (a blood alcohol concentration of 0.05%)
and alcohol-placebo (study 1, part 2). Study 2 examined the
acute effects bromfenac (25 and 50 mg), oxycodone with
paracetamol (5/325 and 10/650 mg), and alprazolam (1 mg)
(Verster et al. 2002b, 2006). Study 3 examined the acute
(day 1) and subchronic (day 4) effects of levocetirizine
(5 mg) and diphenhydramine (50 mg) (Verster et al. 2003a,
b). In all studies, results were compared with those obtained
in a placebo condition.
The on-the-road driving test
Standardized 100-km driving tests (O’ Hanlon et al. 1982;
Verster and Roth 2011a) were performed on a primary
highway during normal traffic, between the cities of Utrecht
and Arnhem. A camera, mounted on the roof of the test
vehicle, measured the vehicle's lateral position relative to
the road delineation. Participants were instructed to drive
with a steady lateral position within the right traffic lane
while maintaining a constant speed of 95 km/h (60 mph).
The amount of weaving of the car, measured by the standard
deviation of the lateral position (SDLP, centimeter), is the
primary outcome parameter. The standard deviation of speed
(kilometer per hour) is a secondary parameter. Duration of the
driving test was approximately 75 min.
Patients were allowed to deviate from the instructions to
overtake a slower-moving vehicle in the same traffic lane.
The vehicle's speed and lateral position were continuously
recorded. A licensed driving instructor who had access to
dual controls sat in the right front seat, guarding the
subject's safety. Tests could be terminated if the driving
instructor or the subject felt it was unsafe to continue.
Before disclosure of treatment blinding, the data were
edited off-line to remove data that were disturbed by
extraneous events (e.g., overtaking maneuvers and traffic
jam), and SDLP values were calculated.
Psychometric tests
All tests were computerized and developed from ERTS
(Beringer 1992). Subjects were seated in a soundproof test
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study. The test battery consisted of validated and reliable
standardized tests measuring different aspects of memory
functioning (Sternberg memory scanning test), psychomo-
tor performance (tracking test), attention (divided attention
test), and information processing (DSST). Quality of
performance was assessed by recording the percentage of
errors on the tests. Before the start of the actual studies,
participants were trained on the tests to attain baseline
performance and to become familiar with test procedures.
Sternberg memory scanning test
This test is designed to measure various aspects of working
memory. Working memory is especially important at the
strategic/navigational level of driving behavior (e.g., re-
membering which side-way should be taken).
After learning a memory set of one to five digits (ranging
from 0 to 9), a single digit (or probe) was presented on the
computer screen. Subjects were instructed to indicate by
button press whether the probe was part of the memory set
(presented, right hand button) or not (not presented, left hand
button). A total of 100 different memory sets were presented.
Mean reaction time (RT, millisecond) and percent errors are
the parameters of interest. Time on task is ±12 min.
Continuous tracking test
This test is designed to measure psychomotor coordination.
Tracking skills are especially important at the operational/
control level of driving behavior (e.g., keeping the car in a
steady position within the lane).
Subjects were instructed to keep an unstable bar in the
middle of a horizontal plane by counteracting or reverse its
movements with the aid of a computer mouse. If the
unstable bar hit the edges of the plane, they had to start again.
An easy version (λ=150) and a hard version (λ=300) of the
tracking test were conducted (lambda is a measure of
instability of the moving bar: the higher lambda, the more
difficult the task). The parameter for tracking accuracy is the
root mean square (R.M.S.) of the deviation of the unstable
bar. Time on task is ±8 min.
Divided attention test
Divided attention is especially important at the maneuvering/
tactical level of driving behavior (e.g., passing another car
while changing gear).
Simultaneously, the easy tracking test (right hand) and a
memory scanning test (fixed memory set size of four digits,
left hand) were performed. Subsequently, digits (ranging
from 0 to 9) were presented on the computer screen, and
participants had to indicate by button press whether the
digit was part of the memory set or not. Parameters are the
R.M.S., the mean reaction time (milliseconds) and percent
errors. Time on task is ±8.5 min.
Digit symbol substitution test
This test is designed to measure information processing, an
ability that is important at all levels of driving behavior.
The digit symbol substitution test (DSST) is a paper-and-
pencil test in which subjects have to match accompanying
symbols and digits. Subjects were instructed to complete as
many pairs as possible within 90 s. Different versions of the
tests were used every test day. The number of correct
completed pairs was the variable of interest.
Statistical analysis
For each treatment, difference scores from placebo were
calculated. This was done for each dependent variable. The
data of the three studies were combined into a single dataset
to allow comparisons between changes in the primary
parameter of the driving test (SDLP) and difference scores
of the psychometric test variables. Pearson r correlations
were computed (significance was established if p<0.05,
two-tailed). The analyses were done for all data together, as
well as for the individual drug treatments. Finally, a step-
forward regression analysis was conducted to determine if a
combination of test variables adequately predicts driving
performance (SDLP).
Results
Data from N=604 driving tests (N=96 participants) and
corresponding psychometric tests was available for the
statistical analysis. For the difference scores from placebo,
at o t a lo fN=431 comparisons could be made. Tables 1 and 2
show the correlations and their significance between differ-
ence scores from placebo for SDLP and parameters of the
psychometric tests.
Best correlations are found for tracking and the divided
attention test. However, the predictive validity of the parameter
that correlates best with SDLP (tracking in the divided
attention test) is only 22%. Data for individual drugs show
comparable results, but not consistently. The relative small
number of subjects for individual drugs may have had an
impact on the observed correlations. Also, no clear dose–
responserelationshipwasobserved.Forexample,performance
on the tracking tests and tracking in the divided attention test
correlated significant with SDLP of the low dose of bromfenac
(25 mg) but not with SDLP of the high dose (50 mg).
To determine whether a combination of test parameters
would show a higher predictive validity to changes in
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DSST was excluded after a first analysis because the test
did not contribute to the predictive validity. Table 3 shows
the results of the regression analysis including the remain-
ing test parameters.
The combination of five parameters, hard tracking,
tracking, and reaction time of the divided attention test,
and reaction time and percentage of errors of the Sternberg
memory scanning test, together had a predictive validity of
33.4%. The parameters easy tracking and percentage of
Table 1 Difference scores from placebo for the tracking test and divided attention test
Treatment N ΔSDLP Tracking test Divided attention test
Easy Hard Tracking RT Errors (%)
Zolpidem (20 mg) 30 +10.41
a 0.694** 0.602** 0.660** 0.599** 0.445*
Alprazolam (1 mg) 18 +9.62
a 0.447 0.875** 0.693** 0.372 −0.025
Zolpidem (10 mg) 30 +3.35
a 0.245 0.387* 0.250 0.348 0.282
Diphenhydramine (50 mg, day 1) 48 +2.74
a 0.252 0.285* 0.255 0.012 0.238
Oxycodone/paracetamol (10/650 mg) 18 +1.87 0.246 0.630** 0.496* 0.262 0.280
Diphenhydramine (50 mg, day 4) 48 +1.56
a −0.133 0.031 0.224 −0.166 0.014
Alcohol (BAC=0.05%) 29 +1.03
a 0.185 0.072 0.065 0.298 0.295
Bromfenac (50 mg) 18 +0.51 0.225 0.241 0.092 0.056 0.337
Levocetirizine (5 mg, day 4) 48 +0.46 0.167 0.330* 0.397** 0.187 0.286*
Zaleplon (10 mg) 30 −0.45 0.229 0.201 0.442* 0.265 0.031
Zaleplon (20 mg) 30 +0.43 0.039 0.292 0.079 0.289 −0.176
Levocetirizine (5 mg, day 1) 48 +0.22 0.029 0.459** 0.229 0.263 0.025
Oxycodone/paracetamol (5/325 mg) 18 −0.65 0.598** 0.719** 0.536* 0.286 0.257
Bromfenac (25 mg) 18 −0.66 0.545* 0.415 0.539* 0.109 −0.050
Overall 491 +2.09 0.412** 0.444** 0.470** 0.420** 0.219**
N=431 N=431 N=431 N=431 N=431
RT reaction time, SDLP standard deviation of lateral position, N number of subjects
*p<0.05, **p<0.01; significance of correlation
aSDLP differed significantly from placebo
Table 2 Difference scores from
placebo for parameters of the
Sternberg memory scanning test
and DSST
RT reaction time, SDLP standard
deviation of lateral position,
DSST digit symbol substitution
test, N number of subjects, N/D






Treatment N ΔSDLP Sternberg memory scanning DSST
RT Errors (%)
Zolpidem (20 mg) 30 +10.41
a 0.713** 0.344 −0.623**
Alprazolam (1 mg) 18 +9.62
a 0.510* 0.391 N/D
Zolpidem (10 mg) 30 +3.35
a 0.333 0.256 0.034
Diphenhydramine (50 mg, day 1) 48 +2.74
a 0.156 0.412** N/D
Oxycodone/paracetamol (10/650 mg) 18 +1.87 0.375 0.276 N/D
Diphenhydramine (50 mg, day 4) 48 +1.56
a 0.050 −0.093 N/D
Alcohol (BAC=0.05%) 29 +1.03
a 0.261 0.050 −0.070
Bromfenac (50 mg) 18 +0.51 −0.071 0.247 N/D
Levocetirizine (5 mg, day 4) 48 +0.46 0.055 −0.225 N/D
Zaleplon (10 mg) 30 −0.45 0.308 −0.300 −0.267
Zaleplon (20 mg) 30 +0.43 0.326 −0.106 −0.148
Levocetirizine (5 mg, day 1) 48 +0.22 0.046 −0.155 N/D
Oxycodone/paracetamol (5/325 mg) 18 −0.65 0.349 0.313 N/D
Bromfenac (25 mg) 18 −0.66 0.193 0.113 N/D
Overall 491 +2.09 0.435** 0.150** −0.396**
N=431 N=431 N=149
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contribute to the predictive validity of the model.
Discussion
The objective of the presented analyses was to determine to
what extent performance on the psychometric tests predicts
on-the-road driving performance. The data show that our
laboratory test, composed of a variety of skills and abilities
related to driving has insufficient power to predict on-road
driving performance, as expressed in SDLP. Although some
skills such as tracking performance correlate well with road
tracking (SDLP), the tests measuring tracking skills are not
suitable to replace on-road testing. Tables 1 and 2 show that
impairment found on the road (i.e., significant SDLP
increment relative to placebo) is not consistently seen for
parameters of the psychometric tests. Also, sometimes
skills related to driving are unimpaired when tested in
isolation, whereas the on-road driving assessment shows
significant impairment. Taken together, the results of the
analyses do not advocate replacing on-road driving assess-
ments by psychometric tests measuring related skills and
abilities.
The studies that were used for the analyses included a
limited number of psychometric tests. These tests were
carefully selected, based on the models of driving perfor-
mance described in the introduction of this paper, and the
quality of the tests. It was aimed to include tests that had a
clear rationale and measured psychological constructs that
are relevant to driving. For example, the Sternberg memory
scanning test is based on a sound theory of short-term
memory and information processing theory, and a compre-
hensive background literature is available on the test and its
parameters (Sternberg 1966, 1975). One of the fundamental
propositions of information processing theory is that the
capacity of the cognitive systems is limited (Schneider and
Shiffrin 1977; Shiffrin and Schneider 1977). Dual tasks,
such as the divided attention test included in the present test
battery, are used to investigate how subjects allocate
resources among the tasks and how this affects perfor-
mance. In the divided attention test, attention is divided
among two components that are vital to driving a car. That
is, tracking places demands on motor-related resources,
whereas memory scanning places demands on working
memory. It is therefore not surprising that its parameters,
tested individual or in the divided attention test, correlate
significant with SDLP, and do so better than parameters
from tests that are less clearly related to driving.
This comparison of psychometric test results with
SDLP, measured on the road in normal traffic, confirms
previous findings by Ramaekers (2003) that results from
psychometric tests poorly predict SDLP. The current
analysis also found that tracking tests showed the best
correlation with SDLP. Combining the test parameters
increases the predictive validity only by about 10%,
relative to individual tests.
In the past, Volkerts et al. (1992) compared performance
on the on-the-road driving test with measurements in a
driving simulator. The TS2 driving simulator test consisted
of a number of subsequent curve-following maneuvers
(road tracking), while simultaneously, subjects had to react
to visual signs by button press. The number of correct
maneuvers and reaction time were the two outcome
measures. Treatments (lormetazepam 1 mg, oxazepam
50 mg, and placebo) were administered and subjects
performed an on-road driving test and simulator driving
test the morning following night 1 and night 2. On both test
Table 3 Results from the
stepwise regression analysis to
determine which test parameters
predict changes in SDLP
RT reaction time
Model Included variables RR
2 Adjusted R
2 Significance
1 Tracking divided attention test 0.470 0.221 0.219 p=0.0001
2 Tracking divided attention test 0.531 0.282 0.279 p=0.0001
RT Sternberg memory scanning test
3 Tracking divided attention test 0.562 0.316 0.311 p=0.0001
RT Sternberg memory scanning test
Tracking (hard condition)
4 Tracking divided attention test 0.578 0.334 0.327 p=0.001
RT Sternberg memory scanning test
Tracking (hard condition)
Error percent Sternberg memory scanning test
5 Tracking divided attention test 0.585 0.342 0.334 p=0.020
RT Sternberg memory scanning test
Tracking (hard condition)
Error percent Sternberg memory scanning test
RT divided attention test
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pam and lormetazepam in the morning session, but not in
the afternoon. In contrast, in the driving simulator, the
drugs did not significantly impair performance, and no
significant correlation was reported between its parameters
and SDLP. This study showed that driving simulator results
poorly predicted SDLP. It would be interested to see if
SDLP measured in more sophisticated driving simulators is
related to on-road assessment of the same parameter. Future
studies should also examine other psychometric tests and
their relationship to actual driving.
The results of our analyses do not mean that psycho-
metric tests are useless or can be omitted when evaluating
potential adverse effects of CNS drugs. On the contrary, it is
of importance that these tests are conducted because they
provide supportive and or additional information to that
obtained by on-road assessments. Whereas SDLP can be
regarded as a measure of overall vehicle control, it does not
give information on the specific skills and abilities that led
to performance impairment. Information on which skills
and abilities are more or less impaired can be obtained by
using a suitable psychometric test battery. In addition,
psychometric tests enable testing skills and abilities related
to risk taking and avoidance that due to safely limitations
cannot be conducted in normal traffic.
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